A Phase I Study of Autologous Bone Marrow Transplantation with Stem Cell Gene Marking in Multiple Myeloma. The Toronto Hospital, Ontario, Canada
- 1 January 1995
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 6 (1), 107-119
- https://doi.org/10.1089/hum.1995.6.1-107
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). The University of Texas M.D. Anderson Cancer CenterHuman Gene Therapy, 1993
- A Model for Predicting the Risk of Cancer Consequent to Retroviral Gene TherapyHuman Gene Therapy, 1992
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Interleukin-2 (National Institutes of Health)Human Gene Therapy, 1992
- No Retroviremia or Pathology in Long-Term Follow-Up of Monkeys Exposed to a Murine Amphotropic RetrovirusHuman Gene Therapy, 1991
- Amphotropic Murine Leukemia Retrovirus Is Not an Acute Pathogen for PrimatesHuman Gene Therapy, 1990
- Protection of uninfected human bone marrow cells in long-term culture from G418 toxicity after retroviral-mediated transfer of the NEOr geneExperimental Cell Research, 1988
- Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer.The Journal of Experimental Medicine, 1987
- Developmental potential and dynamic behavior of hematopoietic stem cellsCell, 1986